CH639102A5 - Process for the preparation of recognins, their complexes, of antirecognins and their complexes and use of the complex prepared - Google Patents

Process for the preparation of recognins, their complexes, of antirecognins and their complexes and use of the complex prepared Download PDF

Info

Publication number
CH639102A5
CH639102A5 CH1343075A CH1343075A CH639102A5 CH 639102 A5 CH639102 A5 CH 639102A5 CH 1343075 A CH1343075 A CH 1343075A CH 1343075 A CH1343075 A CH 1343075A CH 639102 A5 CH639102 A5 CH 639102A5
Authority
CH
Switzerland
Prior art keywords
recognin
carrier
astrocytin
malignin
tag
Prior art date
Application number
CH1343075A
Other languages
German (de)
English (en)
Inventor
Samuel Dr Bogoch
Original Assignee
Bogoch Samuel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bogoch Samuel filed Critical Bogoch Samuel
Publication of CH639102A5 publication Critical patent/CH639102A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
CH1343075A 1975-02-18 1975-10-16 Process for the preparation of recognins, their complexes, of antirecognins and their complexes and use of the complex prepared CH639102A5 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55043275A 1975-02-18 1975-02-18
US55307575A 1975-02-25 1975-02-25
US62111275A 1975-10-09 1975-10-09

Publications (1)

Publication Number Publication Date
CH639102A5 true CH639102A5 (en) 1983-10-31

Family

ID=27415588

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1343075A CH639102A5 (en) 1975-02-18 1975-10-16 Process for the preparation of recognins, their complexes, of antirecognins and their complexes and use of the complex prepared

Country Status (4)

Country Link
JP (2) JPH0146520B2 (enExample)
CH (1) CH639102A5 (enExample)
DE (1) DE2606257A1 (enExample)
GB (1) GB1533464A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214B1 (en) * 1978-07-07 1985-10-23 Samuel Dr. Bogoch Product for detecting the presence of cancerous or malignant tumor cells
GB2043890B (en) * 1979-01-30 1983-09-07 Otsuka Pharma Co Ltd Determination of tumour associated glycolinkage and diagnosis of cancer
ATE8897T1 (de) * 1979-03-09 1984-08-15 Samuel Dr. Bogoch Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren.

Also Published As

Publication number Publication date
DE2606257A1 (de) 1976-08-26
JPS51108001A (enExample) 1976-09-25
JPH0257671B2 (enExample) 1990-12-05
GB1533464A (en) 1978-11-22
JPH0146520B2 (enExample) 1989-10-09
JPH01112163A (ja) 1989-04-28

Similar Documents

Publication Publication Date Title
DE69823361T2 (de) Herstellung von kollagen
Casselman The in vitro preparation and histochemical properties of substances resembling ceroid
DE69030956T2 (de) Inhibierung des Transformierenden Wachstumsfaktors zur Verhinderung der Anhäufung Extrazellulärer Matrix
EP0021152B1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
DE2546166A1 (de) Gegerbte thrombozyten
EP0374778A2 (de) Verfahren zur Proteinimmobilisierung an einer Festphase, so hergestellte Protein tragende Festphase sowie deren Verwendung
EP0220537A1 (de) Thymusextraktfraktionen enthaltende pharmazeutische Zusammensetzung
US4196186A (en) Method for diagnosing malignant gliol brain tumors
DE3751316T2 (de) Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung.
DE69722900T2 (de) Verfahren zur Herstellung von einer stabilen Troponin-Zubereitung und ihre Verwendung als Kalibrator/Kontrolle in Immunoassays
US4624932A (en) Recognins and their chemoreciprocals
DE2606257A1 (de) Recognine
DE68925457T2 (de) Diagnoseverfahren für infektionskrankheiten sowie verfahren zum nachweis und identifizierung von mikroorganismen
DE2546670A1 (de) Recognine
EP1242825A2 (de) Gewinnung von biologischen komponenten aus körperflüssigkeiten
AT392003B (de) Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat
DE3872235T2 (de) Allgemeiner krebsverbundener faktor, durch scm erkannt, seine praeparation und sein verwendungsverfahren.
CH640244A5 (en) Biologically active substance
US4624931A (en) Recognins and their chemoreciprocals
CH617853A5 (en) Process for the preparation of a tumour polypeptide antigen
DE3222452A1 (de) Verfahren zur erkennung aneuploider zellen
DE2205897C3 (de) Verfahren zur Herstellung von Antithymozytenserum
EP0013306B1 (de) Verfahren zur Bestimmung eines opsonierenden oberflächenbindenden alpha-2-Glykoproteins
DD140503A5 (de) Diagnostisches verfahren
DE1916132A1 (de) Papierstreifen zur klinischen Diagnose und Verfahren zu seiner Herstellung

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased